01 16Bayer Inc.
01 42396561
02 42547113
03 42624310
04 42823159
01 4RIVAROXABAN
02 12Rivaroxaban
01 4TABLET
02 12Tablet
01 42020-12-11
02 42024-11-13
03 82026-09-22
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Brand Name : XARELTO
Patent Number : 2396561
Filing Date : 2000-12-11
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Brand Name : XARELTO
Patent Number : 2396561
Filing Date : 2000-12-11
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Brand Name : XARELTO
Patent Number : 2396561
Filing Date : 2000-12-11
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Brand Name : XARELTO
Patent Number : 2624310
Filing Date : 2006-09-22
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Brand Name : XARELTO
Patent Number : 2547113
Filing Date : 2004-11-13
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Brand Name : XARELTO
Patent Number : 2823159
Filing Date : 2006-09-22
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Brand Name : XARELTO
Patent Number : 2624310
Filing Date : 2006-09-22
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Brand Name : XARELTO
Patent Number : 2547113
Filing Date : 2004-11-13
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Brand Name : XARELTO
Patent Number : 2823159
Filing Date : 2006-09-22
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Brand Name : XARELTO
Patent Number : 2624310
Filing Date : 2006-09-22
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
